Letter about the temporary class drug order on methiopropamine.
PDF, 76.6KB, 3 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This letter from the chair of the Advisory Council on the Misuse of Drugs (ACMD) to ministers gives advice about the temporary class drug order on methiopropamine. It recommends extending the order for a further 12 months.